China Drug Approvals | 2022 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenter

Pharmaceutical Companies Deals and acquisitions | Sanofi | Amgen | Pfizer | 2022 | iPharmaCenter

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter

How is AbbVie bracing for the impact of Humira’s biosimilars? | iPharmaCenter

TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022

2022 FDA Drug Approvals | US Pharma News | iPharmaCenter

Top-selling cancer drugs | 2022 | 2023 | Best cancer products | iPharmaCenter

Top 5 drug launches in 2023 that has potential to be blockbusters | iPharmaCenter

Expected best selling drugs of 2023

Access to Medicines | 2021 | 2022 | News | iPharmaCenter | GSK tops list

Multiple Myeloma | News | Blogs | FDA and EMA approvals | Updates on clinical guidelines

Merck and Moderna agreed to develop and commercialize a cancer vaccine | iPharmaCenter

Sanofi gave a statement on the U.S. Zantac litigation | iPharmaCenter

AbbVie's JAK inhibitor, Rinvoq, was approved for UC and nr-axSpA in Europe | iPharmaCenter

Top 20 healthcare companies | iPharmaCenter | Top healthcare companies by revenues

Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter

Health Canada Drug Approvals | Healthcare and Pharmaceutical News of Canada | News | Blogs | Canada

Top pharmaceutical companies by revenues in 2021 | Top 10 pharma companies | iPharmaCenter